Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-044500·Aclaris Therapeutics, Inc.
Schedule 13G ownership disclosure
Aclaris Therapeutics Inc
Common Stock, par value $0.00001 per share · CUSIP: 00461U105
Event date: 2025-04-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Millennium Management LLC
Shares: 5,543,138.00 · Class: 5.1%
- Millennium Group Management LLC
Shares: 5,543,138.00 · Class: 5.1%
- Israel A. Englander
Shares: 5,543,138.00 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-044500
- Form type
- SCHEDULE 13G
- Filer
- Aclaris Therapeutics, Inc.
- CIK
- CIK 1557746
- Filed
- May 05, 2025
- Reporting period
- Apr 28, 2025
- Description
- Schedule 13G beneficial ownership